Adjuvant chemotherapy in embryonal carcinoma of the testis.
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001761:Bleomycin / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage; D003609:Dactinomycin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006062:Gonadotropins / Q000097:blood; D006801:Humans; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D008926:Plicamycin / Q000627:therapeutic use; D013724:Teratoma / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D013736:Testicular Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D013737:Testis / Q000473:pathology; D000509:alpha-Fetoproteins / Q000032:analysis
D000970:Antineoplastic Agents; D006062:Gonadotropins; D000509:alpha-Fetoproteins; D001761:Bleomycin; D003609:Dactinomycin; D003520:Cyclophosphamide; D007986:Luteinizing Hormone; D008926:Plicamycin; D008727:Methotrexate